Table 4. Prospective Pharmacophore Model Performance Based on Bioactivity Results.
Model (Found inhibitor) | Tested virtual hits | Active virtual hits | Number of active hits | Hit rate (%) |
---|---|---|---|---|
SB1 | 4 | SC45 | 1 | 25 |
SB2 | 3 | SC23 | 1 | 33.3 |
LB3 | 5 | SC45 | 1 | 20 |
LB6 | 5 | SC32, SC34, SC37 | 3 | 60 |
LB7 | 4 | SC22 | 1 | 25 |
LB8 | 3 | SC27 | 1 | 33.3 |
LB9 | 4 | 0 | 0 | 0 |
LB10 | 4 | SC25 | 1 | 25 |
LB11 | 3 | SC34 | 1 | 33.3 |
DS2 | 2 | SC34 | 1 | 50 |
DS5 | 4 | SC24 | 1 | 25 |
DS8 | 2 | SC24 | 1 | 50 |
DS9 | 5 | SC6, SC14, SC24, SC25 | 4 | 80 |
DS12 | 3 | SC25 | 1 | 33.3 |